Company Filing History:
2 out of 30 
2 out of 453 
2 out of 832,718 Years Active: 2011-2012
Title: Innovations by Pablo Engel Rocamora in Cancer Treatment
Introduction
Pablo Engel Rocamora, an esteemed inventor based in Barcelona, Spain, has made significant contributions to the field of medical science, particularly in cancer treatment and immune regulation. With two patents to his name, Rocamora's work showcases the innovative approaches to addressing serious health challenges.
Latest Patents
Rocamora's latest patents focus on groundbreaking methods of treating cancer. The first patent discloses methods for treating subjects with cancers, which includes the administration of an effective amount of an early activation molecule agonist, antagonist, or depletor. Alongside this, human monoclonal antibodies specific to the early activation molecules and methods of use are also presented.
The second patent delves into immune regulation based on the depletion of CD69+ cells. This patent outlines methods for treating subjects with disorders characterized by unwanted immune responses. It also suggests administering an effective amount of an early activation molecule agonist, antagonist, or depletor, in conjunction with specific human monoclonal antibodies.
Career Highlights
Throughout his career, Rocamora has worked with renowned institutions such as the Autonomous University of Madrid and the Spanish National Research Council (Consejo Superior de Investigaciones Científicas). His involvement in these prestigious organizations has allowed him to collaborate on various research projects, significantly advancing knowledge in his field.
Collaborations
Rocamora has collaborated with notable colleagues, including Francisco Sanchez-Madrid and David Sancho Madrid. These partnerships have greatly contributed to the development of his innovative solutions in medical science.
Conclusion
Pablo Engel Rocamora continues to push the boundaries of innovation within cancer treatment and immune regulation. His patented methods represent a significant leap forward in medical technology and have the potential to improve patient outcomes. As research progresses, Rocamora's contributions to science are likely to pave the way for groundbreaking advancements in healthcare.